142 related articles for article (PubMed ID: 9347835)
1. Biology of esophageal cancer and the role of combined modality therapy.
Thomas CR
Surg Clin North Am; 1997 Oct; 77(5):1139-67. PubMed ID: 9347835
[TBL] [Abstract][Full Text] [Related]
2. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection with and without chemotherapy in oesophageal cancer.
Rath GK; Sharma DN; Shukla NK
Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387980
[No Abstract] [Full Text] [Related]
4. Surgical resection with and without chemotherapy in oesophageal cancer.
Chander S
Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
[No Abstract] [Full Text] [Related]
5. [Concomitant chemoradiotherapy of cancer of the esophagus].
Calais G
Cancer Radiother; 1998 Dec; 2(6):689-95. PubMed ID: 9922774
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant therapy of adenocarcinomas of the upper gastrointestinal tract. Status of radiotherapy].
Semrau R; Vallböhmer D; Hölscher AH; Müller RP
Chirurg; 2009 Nov; 80(11):1035-41. PubMed ID: 19820906
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant treatment of oesophageal adenocarcinoma.
Robb WB; Naughton P; Walsh TN
Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study.
De Vita F; Di Martino N; Orditura M; Cosenza A; Galizia G; Del Genio A; Catalano G
Chest; 2002 Oct; 122(4):1302-8. PubMed ID: 12377857
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
10. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy and esophageal cancer.
Shridhar R; Almhanna K; Meredith KL; Biagioli MC; Chuong MD; Cruz A; Hoffe SE
Cancer Control; 2013 Apr; 20(2):97-110. PubMed ID: 23571700
[TBL] [Abstract][Full Text] [Related]
12. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
Mooney MM
J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
[TBL] [Abstract][Full Text] [Related]
15. An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between Western and Eastern standards.
Nishimaki T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):231-3. PubMed ID: 16977290
[No Abstract] [Full Text] [Related]
16. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
17. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
Int J Radiat Oncol Biol Phys; 1992; 24(4):633-42. PubMed ID: 1429085
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
19. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
20. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
